Search results
Alzheimer's and dementia research – find the latest information on research funding, grants, clinical trials and global research news. Get information and resources for Alzheimer's and other dementias from the Alzheimer's Association.
Researchers associated with the Center are focused on understanding the earliest stages of Alzheimer's disease and related disorders, and on improving care of patients in the symptomatic phases of disease.
Alzheimer's disease is a progressive neurodegenerative disease that impairs memory and cognitive judgment and is often accompanied by mood swings, disorientation and eventually delirium. It...
Over the past year, NIH has conducted and funded remarkable Alzheimer’s and related dementias research that is bringing us closer to effective prevention, diagnostics, and treatments and improved care for the people living with these conditions, along with better support for care partners.
News about Alzheimer's disease, Alzheimer’s disease, diet
News about pomegranates, Alzheimer’s disease, urolithin A
Also in the news
Nov 8, 2022 · Over the past year, NIH has conducted and funded remarkable Alzheimer’s and related dementias research that is bringing us closer to effective prevention, diagnostics, and treatments and improved care for the people living with these conditions, along with better support for care partners.
Nov 28, 2022 · Herein, we provide a comprehensive review on Alzheimer’s disease highlighting the mainstream hypotheses explaining disease pathophysiology as well as current disease treatments and drug discovery projects.
Nov 16, 2022 · Diagnose. Treat. Care (PDF, 17.5M), a 2022 scientific progress report. This report provides a comprehensive overview of the meaningful progress researchers made from April 2021 through March 2022 to address the enormous challenges of Alzheimer’s and related dementia diseases. A few highlights of NIH-funded progress included:
Mar 13, 2024 · Being able to quantify how long a disease-modifying drug can delay or halt the progression of Alzheimer’s disease could change how researchers understand — and communicate — its benefits.
Dec 8, 2020 · Alzheimer’s disease (AD) is a disorder that causes degeneration of the cells in the brain and it is the main cause of dementia, which is characterized by a decline in thinking and independence in personal daily activities.
Sep 4, 2023 · This Review summarizes recent advances in biomarkers and therapies for Alzheimer disease—the products of decades of research—and discusses the challenges, gaps and clinical implications.
